Xconomy

From Immuneering, Led by Young CEO and Mentor, Aims to Pick Which Cancer Drugs Should Work:

immuneering
immuneering

Immuneering is developing predictive tests for whether cancer drugs will work

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.